KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Pfizer (PFE) Curent Deferred Tax Liability (2009)

Pfizer (PFE) reported Curent Deferred Tax Liability of $1.8 billion for Q3 2009.

Pfizer (PFE) has 1 years of Curent Deferred Tax Liability data on file, last reported at $1.8 billion in Q3 2009.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Curent Deferred Tax (Qtr)
1	Novartis Ag	107,124,802.25 Bn	107,124,802.25 Bn	-	-
2	Eli Lilly	969.00 Bn	963.72 Bn	16.22 Bn	-
3	Johnson & Johnson	539.46 Bn	517.41 Bn	15.96 Bn	-
4	AbbVie	376.92 Bn	367.57 Bn	10.78 Bn	-
5	Merck	285.00 Bn	279.35 Bn	12.09 Bn	-
6	Amgen	177.58 Bn	165.55 Bn	5.87 Bn	-
7	Gilead Sciences	163.22 Bn	155.50 Bn	5.52 Bn	-
8	Pfizer	145.86 Bn	133.09 Bn	-1.21 Bn	-
9	Bristol Myers Squibb	111.90 Bn	101.44 Bn	8.07 Bn	-
10	Gsk	88.34 Bn	83.66 Bn	-	-

Historic Data

Download Data 🔒

Date	Value
Sep 27, 2009	1.82 Bn
Sep 27, 2009	1.82 Bn